Recruiting

RD-X10

Sponsor:

David Moss

Code:

NCT07610967

Conditions

COVID-19 Respiratory Infection

Influenza

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Interventions

RD-X19

RD-X19 Sham

Study Details

Brief summary:

The purpose of trial is to determine if daily usage of a photobiomodulation device will decrease the incidence of upper respiratory tract infections (URI) due to COVID, influenza or other viruses.The RD-X10 device is handheld, can be self-administered, and has been shown to be safe in invivo studies.

Conditions

COVID-19 Respiratory Infection

Influenza

Study ID

NCT07610967

Start date

Oct 1, 2026

Status verified date

Oct, 2026

Completion date

Jun, 2028

Anticipated

Primary completion date

Jun, 2028

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Inclusion Criteria:

  • Active Duty and DoD Beneficiaries (i.e. former military, spouse, dependent child) aged 18 years and older who work in the Mike O'Callaghan Military Medical Center at Nellis Air Force Base.

Exclusion Criteria:

  • Unable to comfortably insert RD-X19 into the mouth and keep in place for 5 minutes
  • Plans for head, neck or mouth surgery during the study period
  • Plans for major dental procedures (ie implants, wisdom teeth extraction etc) during the study

Study Design

Enrollment

130 participants

Anticipated

Allocation

Randomized

Intervention Model

Parallel Assignment

Primary purpose

Treatment

Interventions and Outcome Measures

Arms

experimental: Group 1: Active RD-X19 every other day for 3 months

sham comparator: Group 2: Sham RD-X19 every other day for 3 months

Interventions

RD-X19

  • Subject will be given the RD-X19 device and shown how to use the device
  • Subjects will be instructed to use the device for 5 minutes every other day
  • Subject will be given "Instructions for Treatment" handout

RD-X19 Sham

  • Subject will be given the sham RD-X19 device and shown how to use the device
  • Subjects will be instructed to use the sham device for 5 minutes every other day
  • Subject will be given "Instructions for Treatment" handout

Primary outcome measure

  • difference in PCR confirmed URI (any virus) [ Time Frame: visit 2 (week 2), visit 3 (week 4), visit 4 (week 6), visit 5 (week 8), visit 6 (week 10), visit 7 (week 12) ]

Central Contacts and Locations

Central contacts

Sandra Huffman

7026533583Sandra.g.huffman.ctr@health.mil

Locations

Mike O'Callaghan Military Medical Center

Recruiting

Nellis Air Force Base, Nevada, United States, 89191

Contacts

Sandra Huffman, BS

702-653-3583Sandra.g.huffman.ctr@health.mil

More Information

Sponsor

David Moss

Last update posted

Oct 8, 2026

Last verified

Oct, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-10-09. This information was provided to ClinicalTrials.gov by David Moss on 2026-10-08. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.